EDGAR Filing Documents for 0001628280-24-037194

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001628280-24-037194

Filing Date

2024-08-14

Accepted

2024-08-14 16:08:58

Documents

Period of Report

2024-06-30

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	ffntf-20240630.htm iXBRL	10-Q	1212005
2	EX-31.1	ffntf06302024exhibit311.htm	EX-31.1	12739
3	EX-31.2	ffntf06302024exhibit312.htm	EX-31.2	12951
4	EX-32.1	ffntf06302024exhibit321.htm	EX-32.1	12040
	Complete submission text file	0001628280-24-037194.txt		7926315

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	ffntf-20240630.xsd	EX-101.SCH	72888
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	ffntf-20240630_cal.xml	EX-101.CAL	107707
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	ffntf-20240630_def.xml	EX-101.DEF	297917
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	ffntf-20240630_lab.xml	EX-101.LAB	684258
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	ffntf-20240630_pre.xml	EX-101.PRE	483872
97	EXTRACTED XBRL INSTANCE DOCUMENT	ffntf-20240630_htm.xml	XML	1132038

Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054

Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067

4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 834168417 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 241207696
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)